
Roche’s next generation leukaemia drug obinutuzumab has beaten the firm’s ageing blood cancer medicine Rituxan in a late-stage trial. The …

The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …
Clinical research organisation Simbec Research has appointed Professor Trevor Jones CBE as non-executive chairman of the Board of directors. Jones …

AstraZeneca says it has no details on the reasons why three of its employees in China have been questioned by …

Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …

The US regulator has issued a warning letter to a facility operated by Indian drugmaker Wockhardt already subject to an …

UAE ‘s bid to boost domestic drug industry plus facility updates from Penn Pharma and Molecular Profiles head our round-up …

Healthcare agency Strategic North has welcomed its latest recruit Rosalyn Bilton to the team in the role of consultant. Bilton …

Roche has been dealt a blow by NICE, with the health watchdog deciding that MabThera should not be used on …

The Royal Pharmaceutical Society (RPS) has called on doctors to change the way they prescribe in a bid to cut …

The vast majority of men and women diagnosed with malignant melanoma are now surviving the disease, according to a new …
The Welsh government is to fork out a £7.8 million grant package to get English stem cell research company ReNeuron …

A senior GlaxoSmithKline executive has admitted that some of the firm’s staff have broken the law in China as a …

Pharma trading group Celesio AG has announced that Alexander Triebnigg has taken over the management of the Brazilian pharma wholesaler …

A memo from the European pharma lobby group EFPIA has revealed that the industry is trying to ‘mobilise’ patient groups …
The growing promise of pharma’s immunotherapy pipeline for cancer was undoubtedly the hottest topic at this year’s ASCO conference. The …

The Care Quality Commission (CQC) has appointed Andrea Sutcliffe as its first chief inspector of adult social care.Any movements at …
Boehringer Ingelheim has partnered with Healthrageous and United BioSource to establish a new diabetes study to help patients manage their …

Johnson & Johnson doesn’t usually provide specific financials for its over-the-counter pharmaceuticals business, but did so for the first time …

Latest results released this morning from a UK government trial show that off-label use of Roche’s Avastin is just as …